Sign in
  1. Home
  2. Companies
  3. The Procter & Gamble Company
  4. Financial Ratios
The Procter & Gamble Company logo
The Procter & Gamble Company PG
$ 146.44 0.02%
report update icon

Quarterly report 2026-Q3
added 08-04-2026

The Procter & Gamble Company Financial Ratios 2026-2006 | PG

Brief overview of The Procter & Gamble Company's market valuation

Ratios are assessed across five available annual reports in the 2021–2025 interval.

The latest available valuation ratios are P/E 22.18x (median 25.1x), EV/EBITDA 22.17x (median 18.82x), P/S 4.2x (median 4.48x). On average, multiples differ from their five-year medians by only -6.3%. Valuation is near its familiar historical range.

Earnings yield calculated as 1/P/E is about 4.5%, showing current profit per unit of share price.

End-period return metrics are ROE 30.6%, ROA 12.8%, ROCE 39.1%. Current resource returns are convincing and help explain a higher market valuation.

The PEG ratio is 3.88x; investors pay a high price per unit of expected growth.

The cash cycle changed only slightly and ended at -44.4 days.

Overall assessment

The Procter & Gamble Company trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.

Annual Financial Ratios The Procter & Gamble Company

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006

P/E

 21.5 22.2 26.7 25.1 22.7 27.9 25.6 83.0 20.8 15.6 22.5 31.0 18.7 19.9 17.0 14.6 53.2 33.8 40.2 - -

P/S

 4.0 4.2 4.7 4.5 4.2 5.2 4.7 4.8 3.0 3.7 3.6 2.9 2.6 2.7 2.2 2.1 - - - - -

EPS

 6.8 6.7 6.2 6.1 6 5.7 5.1 1.4 3.8 5.8 3.8 2.5 4.2 4.0 3.8 4.1 4.3 4.5 3.9 3.2 -

EV (Enterprise Value)

 408 B 418 B 459 B 433 B 397 B 461 B 391 B 387 B 266 B 297 B 299 B 277 B 283 B 290 B 247 B 240 B 241 B 224 B 272 B -5.35 B -6.69 B

EBITDA per Share

 9.82 9.91 9.08 8.8 8.55 8.4 7.53 6.2 6.54 6.35 5.97 6.02 6.63 6.35 6.42 6.65 2.51 2.62 2.34 - -

EV/EBITDA

 17.8 17.9 21.4 20.8 19.3 22.2 18.8 21.0 14.0 15.8 15.7 14.2 13.2 14.1 11.5 10.8 33.1 29.0 37.7 -0.3 -

PEG

 6.68 3.88 3.26 3.86 3.47 3.76 5.17 -1.35 -0.59 0.3 0.43 -0.77 5.02 3.46 -2.34 -3.16 - - - - -

P/B

 6.4 6.8 7.8 7.8 7.1 8.5 7.1 6.9 3.9 4.3 4.1 3.5 3.1 3.3 2.9 2.5 2.9 2.5 2.9 - -

P/CF

 17.7 19.9 20.0 21.8 20.0 21.7 19.2 27.2 18.2 25.4 19.5 20.0 21.5 20.7 19.7 17.4 11.0 10.5 13.4 - -

ROE %

 29.54 30.55 29.43 31.13 31.46 30.66 27.79 8.26 18.64 27.77 18.33 11.27 16.82 16.62 16.95 17.44 5.42 7.35 7.17 15.43 -

ROA %

 12.68 12.76 12.16 12.13 12.58 11.99 10.79 3.39 8.24 12.73 8.27 5.43 8.07 8.12 8.13 8.53 2.60 3.46 3.48 - -

ROCE %

 36.36 39.12 36.68 38.53 38.02 38.55 33.50 16.26 15.22 15.47 13.95 13.86 13.83 13.54 13.85 14.24 6.81 7.34 5.81 21.62 -

Current Ratio

 1.8 1.7 1.7 1.6 1.7 1.6 1.6 0.7 0.8 0.9 1.1 1.0 0.9 0.8 0.9 0.8 1.9 1.9 1.9 - -

DSO

 25.7 26.6 25.2 23.6 22.5 21.3 23.5 26.7 25.6 25.8 24.4 23.3 28.1 28.2 26.5 27.7 - - - - -

DIO

 66.2 64.6 62.9 59.7 55.9 56.5 54.4 52.7 50.5 51.9 52.3 51.2 58.1 59.4 57.9 66.1 - - - - -

DPO

 132.7 135.6 133.9 125.8 123.8 126.8 120.8 118.2 110.2 108.1 103.4 77.5 72.7 75.5 68.2 71.8 - - - - -

Operating Cycle

 91.8 91.2 88.1 83.4 78.3 77.8 77.9 79.4 76.1 77.6 76.7 74.5 86.2 87.7 84.3 93.8 - - - - -

Cash Conversion Cycle

 -40.9 -44.4 -45.8 -42.5 -45.5 -49.0 -42.9 -38.8 -34.1 -30.4 -26.7 -3.1 13.4 12.2 16.1 22.0 - - - - -

All numbers in USD currency

Quarterly Financial Ratios The Procter & Gamble Company

2026-Q3 2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2 2010-Q1

EPS

 1.66 1.82 1.66 2 1.94 1.58 1.94 1.65 1.44 1.56 1.44 1.89 1.63 1.41 1.63 1.62 3.25 1.37 1.72 1.66 3.39 1.3 1.53 1.69 1.53 1.69 1.47 1.41 1.47 1.41 1.25 1.26 1.25 1.26 0.96 1.09 0.96 1.09 3.01 0.99 3.01 0.99 1.16 0.93 1.16 0.93 0.85 0.71 0.85 0.71 1.24 1.09 1.24 0.92 1.46 1 2.46 0.85 0.59 1.08 0.59 1.08 0.88 1.58 1.11

EBITDA per Share

 2.3 2.64 2.3 2.83 3.05 2.24 2.48 2.77 2.48 1.92 1.92 2.74 2.58 1.84 2.06 2.35 4.65 1.71 2.17 2.36 4.79 1.57 2.2 2.39 2.72 2.39 1.84 2 2.37 2 1.59 1.68 2.08 1.68 1.58 1.7 2.12 1.74 1.5 1.67 2.04 1.68 1.45 1.65 1.95 1.65 1.37 1.63 - 1.38 - 1.68 - - - - - - - - - - - - -

ROE %

 31.34 33.16 32.23 34.04 32.77 30.87 31.15 29.26 31.08 32.77 32.79 34.48 33.95 41.96 41.81 42.43 42.40 43.47 43.18 41.71 41.66 31.74 30.70 30.85 29.87 10.51 10.35 8.12 6.39 21.28 21.53 20.22 19.34 20.43 19.48 29.57 28.96 37.99 37.52 28.01 27.54 19.04 18.49 17.00 15.85 14.15 12.87 14.10 15.52 17.12 18.68 19.82 19.75 21.10 21.09 17.67 17.94 14.09 14.14 15.41 17.56 20.01 3.87 6.76 4.93

ROA %

 13.24 13.95 13.63 14.34 13.75 12.84 12.92 12.01 12.57 13.04 12.74 13.21 12.90 16.28 16.24 16.37 16.42 16.69 16.64 16.37 16.50 12.71 12.39 12.50 12.09 4.34 4.31 3.56 3.11 9.27 9.59 8.97 8.59 9.07 8.73 13.49 13.27 17.40 17.16 12.91 12.82 9.11 8.98 8.24 7.67 6.83 6.20 6.86 7.57 8.38 9.18 9.68 9.61 10.21 10.17 8.52 8.67 6.82 6.88 7.56 8.79 9.96 1.94 3.44 2.39

ROCE %

 37.72 40.52 39.13 41.93 42.11 40.03 40.22 38.14 39.03 40.65 41.14 42.76 41.89 51.95 51.39 52.20 51.89 52.98 52.34 51.91 51.96 41.07 43.79 42.47 40.93 39.60 37.86 35.25 32.68 30.13 27.76 27.77 27.67 27.80 27.77 27.73 27.39 26.78 26.54 25.60 25.26 24.71 24.18 23.52 22.97 22.51 20.74 20.77 20.89 21.86 23.70 24.73 25.15 25.53 25.66 23.21 23.69 20.72 20.93 22.74 23.02 25.70 5.94 6.75 6.64

Current Ratio

 1.7 1.7 1.7 1.7 1.7 1.8 1.7 1.7 1.7 1.7 1.7 1.6 1.6 1.6 1.6 1.6 1.7 1.6 1.6 1.6 1.6 1.6 1.7 1.7 1.6 1.6 1.7 1.7 1.7 1.7 1.8 1.8 1.8 1.8 1.8 1.8 1.9 1.9 1.9 1.8 1.8 1.8 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.9 2.0 1.9 2.0 2.0 1.9 1.9 1.9 1.9 1.9 1.9 2.0 2.0 2.0 2.0 1.9

DSO

 27.1 25.9 27.5 25.9 25.8 28.6 26.2 26.6 26.5 28.1 26.7 25.0 24.7 25.6 25.2 24.1 11.8 25.3 23.7 23.3 10.4 24.1 22.8 21.8 19.3 22.1 25.9 25.9 24.8 25.6 26.4 26.6 25.9 27.6 26.6 26.1 24.1 25.5 25.6 25.1 23.7 25.1 25.5 25.6 24.6 28.6 29.6 29.7 28.1 29.2 31.8 31.8 26.6 29.5 29.8 29.3 25.0 28.5 28.3 27.2 25.9 25.3 - - -

DIO

 66.7 66.0 66.8 62.3 63.1 67.9 62.7 63.2 64.0 65.9 64.2 63.7 62.9 65.9 63.4 61.0 29.4 60.9 55.5 54.1 26.0 61.1 57.5 55.9 54.2 55.0 56.5 54.8 51.6 53.9 53.5 53.4 48.5 53.1 53.2 53.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 128.5 127.2 130.4 126.2 127.0 136.5 130.7 129.5 125.6 129.3 128.9 124.2 117.0 122.5 121.4 125.0 61.0 125.2 121.4 123.0 59.5 131.7 118.2 119.8 119.0 114.0 111.8 116.2 115.8 112.6 104.9 110.7 105.8 108.0 100.6 105.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - 94.3 89.6 - 96.4 88.8 89.0 - 94.0 90.9 87.8 - 91.4 88.6 85.1 41.2 86.2 79.3 77.4 36.4 85.1 80.3 77.7 73.5 77.1 82.4 80.7 76.4 79.5 79.9 79.9 74.4 80.7 79.8 79.4 24.1 25.5 25.6 25.1 23.7 25.1 25.5 25.6 24.6 28.6 29.6 29.7 28.1 29.2 31.8 31.8 26.6 29.5 29.8 29.3 25.0 28.5 28.3 27.2 25.9 - - - -

Cash Conversion Cycle

 - - -36.0 -36.6 - -40.1 -41.9 -38.1 - -35.3 -38.1 -34.8 - -31.1 -32.8 -40.0 -19.8 -39.0 -42.1 -45.6 -23.1 -46.5 -37.9 -42.1 -45.5 -36.9 -29.4 -35.5 -39.5 -33.1 -25.0 -30.8 -31.4 -27.3 -20.8 -26.0 24.1 25.5 25.6 25.1 23.7 25.1 25.5 25.6 24.6 28.6 29.6 29.7 28.1 29.2 31.8 31.8 26.6 29.5 29.8 29.3 25.0 28.5 28.3 27.2 25.9 - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company The Procter & Gamble Company, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Household products industry

Issuer Price % 24h Market Cap Country
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
 		- - $ 9.02 B -
Unilever PLC Unilever PLC
UL
 		$ 64.2 0.15 % $ 140 B britainBritain
LifeVantage Corporation LifeVantage Corporation
LFVN
 		$ 6.25 2.38 % $ 78.3 M usaUSA
Acme United Corporation Acme United Corporation
ACU
 		$ 63.14 0.33 % $ 239 M usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
 		$ 98.55 0.05 % $ 23.9 B usaUSA
Colgate-Palmolive Company Colgate-Palmolive Company
CL
 		$ 88.77 0.23 % $ 71.8 B usaUSA
The Clorox Company The Clorox Company
CLX
 		$ 93.06 0.02 % $ 11.5 B usaUSA
Coty Coty
COTY
 		$ 2.93 0.17 % $ 2.57 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
 		$ 0.98 2.04 % $ 13.1 M chinaChina
The Estée Lauder Companies The Estée Lauder Companies
EL
 		$ 103.86 2.97 % $ 37.6 B usaUSA
e.l.f. Beauty e.l.f. Beauty
ELF
 		$ 109.67 2.1 % $ 6.39 B usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
 		$ 28.87 1.3 % $ 1.37 B usaUSA
Helen of Troy Limited Helen of Troy Limited
HELE
 		$ 28.4 0.78 % $ 653 M bermudaBermuda
Hims & Hers Health Hims & Hers Health
HIMS
 		$ 27.71 0.84 % $ 6.23 B usaUSA
Inter Parfums Inter Parfums
IPAR
 		$ 116.69 2.35 % $ 3.75 B usaUSA
Kimberly-Clark Corporation Kimberly-Clark Corporation
KMB
 		$ 104.96 0.05 % $ 34.8 B usaUSA
Mannatech, Incorporated Mannatech, Incorporated
MTEX
 		$ 9.0 23.46 % $ 17.1 M usaUSA
Nature's Sunshine Products Nature's Sunshine Products
NATR
 		$ 14.02 1.59 % $ 252 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
 		$ 4.84 2.98 % $ 239 M usaUSA
Newell Brands Newell Brands
NWL
 		$ 6.11 0.66 % $ 2.56 B usaUSA
Revlon Revlon
REV
 		- -4.41 % $ 212 M usaUSA
Spectrum Brands Holdings Spectrum Brands Holdings
SPB
 		$ 88.5 0.08 % $ 2.27 B usaUSA
United-Guardian United-Guardian
UG
 		$ 7.14 0.92 % $ 32.8 M usaUSA
USANA Health Sciences USANA Health Sciences
USNA
 		$ 14.96 3.67 % $ 277 M usaUSA